Acquisition
1 min read
Insitro has acquired CombinAble.AI, marking the first exit for an Israeli AI pharma startup. Built b...
The AMW Read
Updates the player map for Vertical AI-Bio via the acquisition of CombinAble.AI by Insitro, illustrating high-velocity venture studio exits in the segment.
NoveltySignificance
Healthcare & Bio · Player Map
Insitro has acquired CombinAble.AI, marking the first exit for an Israeli AI pharma startup. Built by AION Labs, the venture reached acquisition in just 2 years with a rapid 4-month deal process. The integration of physics-informed AI powers Insitro’s new TherML platform, creating a unified engine for small molecules and biologics. This shift to generative design validates the venture studio model as a high-velocity catalyst for biotech. 🚀💊
